Literature DB >> 8448260

Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration.

B Sun1, T Curstedt, G W Song, B Robertson.   

Abstract

Nearly mature newborn rabbits (gestational age 29.5 days) were tracheotomized at birth and received, via the tracheal cannula, 6 ml/kg body weight of a filtered saline suspension of human meconium, 65 or 130 mg/ml. Animals were kept in body plethysmographs and ventilated for 60 min with standardized tidal volume (8-10 ml/kg). Aspiration of meconium caused, in both groups, a statistically significant reduction in lung-thorax compliance, elevated PCO2 in heart blood and reduced alveolar volume density (VV) in histological sections. Both groups responded to treatment with exogenous surfactant (Curosurf, 200 mg/kg) with a moderate, statistically significant improvement in lung-thorax compliance, PCO2 and alveolar VV. Our data indicate that respiratory failure after neonatal meconium aspiration may be influenced favorably by treatment with exogenous surfactant.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448260     DOI: 10.1159/000243917

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  14 in total

1.  Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration.

Authors:  Anne Hilgendorff; Daniel Rawer; Martin Doerner; Erol Tutdibi; Michael Ebsen; Reinhold Schmidt; Andreas Guenther; Ludwig Gortner; Irwin Reiss
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

Review 2.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Lavage administration of dilute surfactant in a piglet model of meconium aspiration.

Authors:  Joan Meister; Venkataraman Balaraman; Malia Ramirez; Catherine F T Uyehara; Jeffrey Killeen; Tercia Ku; Donald Person; David Easa
Journal:  Lung       Date:  2004       Impact factor: 2.584

Review 4.  Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.

Authors:  L R Wiseman; H M Bryson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

5.  Appropriate surfactant usage in 1996.

Authors:  R F Soll
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

6.  New targets for surfactant replacement therapy: experimental and clinical aspects.

Authors:  B Robertson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

7.  Surfactant administration prior to one lung ventilation: physiological and inflammatory correlates in a piglet model.

Authors:  Rahul Bhatia; Thomas H Shaffer; Jobayer Hossain; Alicia Olivant Fisher; Liana M Horner; M Elena Rodriguez; Scott Penfil; Mary C Theroux
Journal:  Pediatr Pulmonol       Date:  2011-05-26

Review 8.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

Review 9.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 10.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.